Investigating olfactory and gustatory dysfunction in patients with restless legs syndrome: A comparative analysis with healthy controls

Olfactory and gustatory dysfunction in RLS

Authors

Keywords:

restless leg syndrome, olfactory dysfunction, gustatory dysfunction, sensory testing

Abstract

Background/Aim: This study aims to examine the correlation between dopamine deficiency and olfactory dysfunction in patients with restless legs syndrome (RLS) and to juxtapose these findings with gustatory function. This comprehension of the relationship may illuminate the pathophysiology of RLS, suggesting possible therapeutic targets.

Methods: We included a total of 100 male participants aged 40 and older, comprising 50 healthy volunteers and 50 patients with RLS. Participants were recruited from the Neurology Clinic at Sultan Abdulhamid Han Training and Research Hospital between September 2016 and April 2017. We objectively assessed olfactory function using the Sniffin’ Sticks Test Battery, while gustatory function was evaluated using the Taste Strip test—participants identified the flavors presented to them.

Results: The mean age of the RLS patient group was 52.5 years, while it was 52.7 years for the healthy group. Olfactory test scores were significantly lower in the RLS group compared to the healthy group (P<0.05). Likewise, gustatory test scores were also significantly lower in RLS patients (P=0.032). A strong positive correlation was observed between the olfactory and gustatory test results (r=+0.72), indicating a significant decline in both sensory functions in RLS patients.

Conclusion: This study reveals a significant association between dopamine deficiency, olfactory dysfunction, and impaired taste perception in RLS patients. These findings suggest that RLS may involve underlying neurodegenerative processes affecting sensory perception. Further research is crucial to shed light on RLS mechanisms, which remain partially understood, and guide the development of targeted therapeutic strategies.

Downloads

Download data is not yet available.

References

Zeeberg P, Olesen J, Jensen R. Efficacy of multidisciplinary treatment in a tertiary referral headache centre. Cephalalgia. 2005 Dec;25(12):1159-67. doi: 10.1111/j.1468-2982.2005.00980. x. PMID: 16305604. DOI: https://doi.org/10.1111/j.1468-2982.2005.00980.x

Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med. 2014 Aug;15(8):860-73. doi: 10.1016/j.sleep.2014.03.025. Epub 2014 May 17. PMID: 25023924. DOI: https://doi.org/10.1016/j.sleep.2014.03.025

Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol. 2001 Mar;18(2):128-47. doi: 10.1097/00004691-200103000-00004. PMID: 11435804. DOI: https://doi.org/10.1097/00004691-200103000-00004

Akpinar S. Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol. 1982 Nov;39(11):739. doi: 10.1001/archneur.1982.00510230065027. PMID: 7126008. DOI: https://doi.org/10.1001/archneur.1982.00510230065027

Trenkwalder C, Allen R, Högl B, Clemens S, Patton S, Schormair B, et al. Comorbidities, treatment, and pathophysiology in restless legs syndrome. Lancet Neurol. 2018 Nov;17(11):994-1005. doi: 10.1016/S1474-4422(18)30311-9. Epub 2018 Sep 21. PMID: 30244828. DOI: https://doi.org/10.1016/S1474-4422(18)30311-9

Bloem BR, Okun MS, Klein C. Parkinson’s disease. Lancet. 2021 Jun 12;397(10291):2284-303. doi: 10.1016/S0140-6736(21)00218-X. Epub 2021 Apr 10. PMID: 33848468. DOI: https://doi.org/10.1016/S0140-6736(21)00218-X

Thomas B, Beal MF. Parkinson’s disease. Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R183-94. doi: 10.1093/hmg/ddm159. PMID: 17911161. DOI: https://doi.org/10.1093/hmg/ddm159

Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol. 2002 Mar;59(3):421-4. doi: 10.1001/archneur.59.3.421. PMID: 11890847. DOI: https://doi.org/10.1001/archneur.59.3.421

Oppo V, Melis M, Melis M, Tomassini Barbarossa I, Cossu G. “Smelling and Tasting” Parkinson’s Disease: Using Senses to Improve the Knowledge of the Disease. Front Aging Neurosci. 2020 Feb 25;12:43. doi: 10.3389/fnagi.2020.00043. PMID: 32161534; PMCID: PMC7052524. DOI: https://doi.org/10.3389/fnagi.2020.00043

Adler CH, Gwinn KA, Newman S. Olfactory function in restless legs syndrome. Mov Disord. 1998 May;13(3):563-5. doi: 10.1002/mds.870130332. PMID: 9613755. DOI: https://doi.org/10.1002/mds.870130332

Beavan M, McNeill A, Proukakis C, Hughes DA, Mehta A, Schapira AH. Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort. JAMA Neurol. 2015 Feb;72(2):201-8. doi: 10.1001/jamaneurol.2014.2950. PMID: 25506732; PMCID: PMC4326672. DOI: https://doi.org/10.1001/jamaneurol.2014.2950

Doty RL. Olfactory dysfunction in Parkinson disease. Nat Rev Neurol. 2012 May 15;8(6):329-39. doi: 10.1038/nrneurol.2012.80. PMID: 22584158. DOI: https://doi.org/10.1038/nrneurol.2012.80

Zhuang S, Yuan X, Ma C, Yang N, Liu CF, Na M, Winkelman JW, Wu S, Gao X. Restless legs syndrome and perceived olfactory and taste dysfunction: A community-based study. Eur J Neurol. 2021 Aug;28(8):2688-93. doi: 10.1111/ene.14890. Epub 2021 May 24. PMID: 33932063. DOI: https://doi.org/10.1111/ene.14890

Pingel J, Ostwald J, Pau HW, Hummel T, Just T. Normative data for a solution-based taste test. Eur Arch Otorhinolaryngol. 2010 Dec;267(12):1911-7. doi: 10.1007/s00405-010-1276-1. Epub 2010 May 22. PMID: 20495925. DOI: https://doi.org/10.1007/s00405-010-1276-1

Duarte AC, Costa AR, Gonçalves I, Quintela T, Preissner R, Santos CRA. The druggability of bitter taste receptors for the treatment of neurodegenerative disorders. Biochem Pharmacol. 2022 Mar;197:114915. doi: 10.1016/j.bcp.2022.114915. Epub 2022 Jan 17. PMID: 35051386. DOI: https://doi.org/10.1016/j.bcp.2022.114915

Haehner A, Hummel T, Reichmann H. Olfactory loss in Parkinson’s disease. Parkinsons Dis. 2011;2011:450939. doi: 10.4061/2011/450939. Epub 2011 Apr 21. PMID: 21687752; PMCID: PMC3109349. DOI: https://doi.org/10.4061/2011/450939

Vosshall LB, Wong AM, Axel R. An olfactory sensory map in the fly brain. Cell. 2000 Jul 21;102(2):147-59. doi: 10.1016/s0092-8674(00)00021-0. PMID: 10943836. DOI: https://doi.org/10.1016/S0092-8674(00)00021-0

Downloads

Published

2024-11-15

Issue

Section

Research Article

How to Cite

1.
Karaoğlan M, Şenol MG, Tekeli H. Investigating olfactory and gustatory dysfunction in patients with restless legs syndrome: A comparative analysis with healthy controls: Olfactory and gustatory dysfunction in RLS. J Surg Med [Internet]. 2024 Nov. 15 [cited 2024 Dec. 8];8(11):175-9. Available from: https://jsurgmed.com/article/view/8150